112 results
S-3ASR
EX-1.2
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
sanctions administered or enforced by the U.S. Department of the Treasury’s Office of Foreign Assets Control, the United Nations Security Council … fees and associated expenses of the Agent’s outside legal counsel for filings with the FINRA Corporate Financing Department in an amount
8-K
EX-99.1
o0gky69
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
8-K
EX-1.1
19buj4wn
15 Jun 23
Other Events
4:23pm
424B5
zhzc9jmn4991cl8r8w
15 Jun 23
Prospectus supplement for primary offering
4:12pm
FWP
hr8vlydhi9f vof
15 Jun 23
Free writing prospectus
7:03am
8-K
EX-99.1
tlj48lerr 9vr6m
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.3
x7c0df xg57
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.1
59lw53qnw5 3j2tt0y5
5 Jun 23
Regulation FD Disclosure
2:24pm